• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Editorial: comorbidities, concomitant medications and potential drug-drug interactions with interferon-free direct-acting anti-viral agents in chronic hepatitis C - authors' reply.

作者信息

Liu Chen-Hua, Kao Jia-Horng

机构信息

Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.

Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.

出版信息

Aliment Pharmacol Ther. 2019 Jan;49(1):117-118. doi: 10.1111/apt.15065.

DOI:10.1111/apt.15065
PMID:30548320
Abstract
摘要

相似文献

1
Editorial: comorbidities, concomitant medications and potential drug-drug interactions with interferon-free direct-acting anti-viral agents in chronic hepatitis C - authors' reply.
Aliment Pharmacol Ther. 2019 Jan;49(1):117-118. doi: 10.1111/apt.15065.
2
Editorial: comorbidities, concomitant medications, and potential drug-drug interactions with interferon-free direct-acting anti-viral agents in chronic hepatitis C.社论：慢性丙型肝炎中合并症、伴随用药以及与无干扰素直接抗病毒药物之间潜在的药物相互作用
Aliment Pharmacol Ther. 2019 Jan;49(1):116-117. doi: 10.1111/apt.15051.
3
Letter: contraindicated drug-drug interactions before and after initiation of direct-acting anti-viral agents in chronic hepatitis C patients in Taiwan. Authors' reply.
Aliment Pharmacol Ther. 2019 Jul;50(1):115-116. doi: 10.1111/apt.15329.
4
Letter: contraindicated drug-drug interactions before and after initiation of direct-acting anti-viral agents in chronic hepatitis C patients in Taiwan.信件：台湾慢性丙型肝炎患者开始使用直接抗病毒药物前后的禁忌药物相互作用
Aliment Pharmacol Ther. 2019 Jul;50(1):113-115. doi: 10.1111/apt.15303.
5
Editorial: are additional tests needed to predict sustained virologic response in hepatitis C treated with interferon-free direct-acting antiviral combinations? Authors' reply.社论：对于接受无干扰素直接作用抗病毒联合治疗的丙型肝炎患者，预测持续病毒学应答是否需要额外检测？作者回复。
Aliment Pharmacol Ther. 2018 Mar;47(6):849-850. doi: 10.1111/apt.14520.
6
Editorial: hepatitis C direct acting antiviral agents and the kidney-authors' reply.社论：丙型肝炎直接抗病毒药物与肾脏——作者回复
Aliment Pharmacol Ther. 2017 Aug;46(3):379-380. doi: 10.1111/apt.14187.
7
Editorial: are additional tests needed to predict sustained virologic response in hepatitis C treated with interferon-free direct-acting antiviral combinations?
Aliment Pharmacol Ther. 2018 Mar;47(6):848-849. doi: 10.1111/apt.14508.
8
Letter: the efficacy of interferon-free regimens in HCV-related Child C cirrhosis needs careful interpretation-Authors' reply.信函：无干扰素方案在丙型肝炎病毒相关Child C级肝硬化中的疗效需谨慎解读——作者回复
Aliment Pharmacol Ther. 2017 Jul;46(1):77. doi: 10.1111/apt.14099.
9
Editorial: interferon-free DAAs are a great boon for patients with hepatitis C and cryoglobulinaemia-Authors' reply.社论：无干扰素直接作用抗病毒药物对丙型肝炎和冷球蛋白血症患者是一大福音——作者回复。
Aliment Pharmacol Ther. 2018 Oct;48(7):772-773. doi: 10.1111/apt.14936.
10
[Algorithmic analysis of potential drug-drug interactions using direct-acting antiviral agents and concomitant medications in chronic hepatitis C].[使用直接作用抗病毒药物和慢性丙型肝炎患者的伴随用药对潜在药物相互作用的算法分析]
Zhonghua Gan Zang Bing Za Zhi. 2018 Mar 20;26(3):209-224. doi: 10.3760/cma.j.issn.1007-3418.2018.03.010.